PDS Biotechnology (PDSB) Tops Q2 EPS by 10c

PDS Biotechnology (NASDAQ: PDSB) reported Q2 EPS of ($0.23), $0.10 better than the analyst estimate of ($0.33).

For earnings history and earnings-related data on PDS Biotechnology (PDSB) click here.

You May Also Be Interested In

• Concentrix Corporation (CNXC) Misses Q2 EPS by 1c; Guides lower than expectations
• Apple Iphone 18 Pro Supplier List, Parts And Photos Exposed In Tata Data Leak - Reuters
• Activist Jana Partners takes 6.3% stake in Alkami Technology, urges sale